Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy

BACKGROUND: Hepatic encephalopathy (HE) is a major complication of cirrhosis with independent prognostic significance. The current management of HE is mainly based on lactulose. Rifaximin has been shown to decrease the risk of HE recurrence in patients with episodic forms. HE can also be persistent....

Descripción completa

Detalles Bibliográficos
Autores principales: Chautant, Fiona, Guillaume, Maeva, Robic, Marie-Angèle, Cadranel, Jean-François, Peron, Jean-Marie, Lison, Hortensia, Cool, Charlène, Bureau, Christophe, Duhalde, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946626/
https://www.ncbi.nlm.nih.gov/pubmed/31984117
http://dx.doi.org/10.4254/wjh.v12.i1.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946626/
https://www.ncbi.nlm.nih.gov/pubmed/31984117
http://dx.doi.org/10.4254/wjh.v12.i1.10

Ejemplares similares